Do analysts prefer HIT or KWY?

Health In Tech presently has a consensus target price of $4.00, indicating a potential upside of 257.14%. Given Health In Tech's stronger consensus rating and higher possible upside, research analysts clearly believe Health In Tech is more favorable than Kingsway Financial Services. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Health In Tech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.50 Kingsway Financial Services 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media favor HIT or KWY?

In the previous week, Kingsway Financial Services had 2 more articles in the media than Health In Tech. MarketBeat recorded 3 mentions for Kingsway Financial Services and 1 mentions for Health In Tech. Kingsway Financial Services' average media sentiment score of 0.70 beat Health In Tech's score of 0.00 indicating that Kingsway Financial Services is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Health In Tech 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Kingsway Financial Services 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer OSG or HIT?

In the previous week, Octave Specialty Group had 2 more articles in the media than Health In Tech. MarketBeat recorded 3 mentions for Octave Specialty Group and 1 mentions for Health In Tech. Octave Specialty Group's average media sentiment score of 0.30 beat Health In Tech's score of 0.00 indicating that Octave Specialty Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Octave Specialty Group 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Health In Tech 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer JRVR or HIT?

In the previous week, James River Group had 3 more articles in the media than Health In Tech. MarketBeat recorded 4 mentions for James River Group and 1 mentions for Health In Tech. James River Group's average media sentiment score of 0.58 beat Health In Tech's score of 0.00 indicating that James River Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment James River Group 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Health In Tech 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend AIFU or HIT?

Health In Tech has a consensus price target of $4.00, indicating a potential upside of 257.14%. Given Health In Tech's stronger consensus rating and higher possible upside, analysts plainly believe Health In Tech is more favorable than AIFU. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AIFU 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Health In Tech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.50

Which has preferable valuation and earnings, AIFU or HIT?

Health In Tech has lower revenue, but higher earnings than AIFU. Health In Tech is trading at a lower price-to-earnings ratio than AIFU, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio AIFU $79.59M 2.81 -$325.38M $228.00 0.16 Health In Tech $34.08M 2.15 -$1.31M -$0.02 N/A

Is AIFU or HIT more profitable?

Company Net Margins Return on Equity Return on Assets AIFU N/A N/A N/A Health In Tech N/A N/A N/A

Does the media refer more to HIT or SLQT?

In the previous week, Health In Tech and Health In Tech both had 1 articles in the media. Health In Tech's average media sentiment score of 0.00 equaled SelectQuote'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Health In Tech 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SelectQuote 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Health In Tech (HIT) Competitors

$1.12 -0.04 (-3.45%)

Closing price 04:00 PM Eastern

Extended Trading

$1.12 0.00 (0.00%)

As of 04:10 PM Eastern

Compare

HIT vs. KWY, OSG, JRVR, AIFU, and SLQT

Should you buy Health In Tech stock or one of its competitors? MarketBeat compares Health In Tech with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Health In Tech include Kingsway Financial Services (KWY), Octave Specialty Group (OSG), James River Group (JRVR), AIFU (AIFU), and SelectQuote (SLQT).

How does Health In Tech compare to Kingsway Financial Services?

Health In Tech (NASDAQ:HIT) and Kingsway Financial Services (NYSE:KWY) are related small-cap companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, dividends, valuation, profitability, risk, earnings, institutional ownership and media sentiment.

Health In Tech has higher earnings, but lower revenue than Kingsway Financial Services. Health In Tech is trading at a lower price-to-earnings ratio than Kingsway Financial Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Health In Tech	$34.08M	2.15	-$1.31M	-$0.02	N/A
Kingsway Financial Services	$134.97M	1.93	-$10.73M	-$0.40	N/A

Health In Tech has a beta of 2.82, suggesting that its share price is 182% more volatile than the broader market. Comparatively, Kingsway Financial Services has a beta of 0.24, suggesting that its share price is 76% less volatile than the broader market.

In the previous week, Kingsway Financial Services had 2 more articles in the media than Health In Tech. MarketBeat recorded 3 mentions for Kingsway Financial Services and 1 mentions for Health In Tech. Kingsway Financial Services' average media sentiment score of 0.70 beat Health In Tech's score of 0.00 indicating that Kingsway Financial Services is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Health In Tech	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Kingsway Financial Services	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Health In Tech presently has a consensus target price of $4.00, indicating a potential upside of 257.14%. Given Health In Tech's stronger consensus rating and higher possible upside, research analysts clearly believe Health In Tech is more favorable than Kingsway Financial Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Health In Tech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50
Kingsway Financial Services	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Health In Tech has a net margin of 0.00% compared to Kingsway Financial Services' net margin of -8.83%. Health In Tech's return on equity of 0.00% beat Kingsway Financial Services' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Health In Tech	N/A	N/A	N/A
Kingsway Financial Services	-8.83%	-72.50%	-5.67%

72.4% of Kingsway Financial Services shares are owned by institutional investors. 77.7% of Health In Tech shares are owned by insiders. Comparatively, 41.4% of Kingsway Financial Services shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Health In Tech beats Kingsway Financial Services on 11 of the 16 factors compared between the two stocks.

How does Health In Tech compare to Octave Specialty Group?

Octave Specialty Group (NYSE:OSG) and Health In Tech (NASDAQ:HIT) are related small-cap companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, media sentiment, dividends, valuation, analyst recommendations, risk and earnings.

Octave Specialty Group presently has a consensus price target of $15.00, indicating a potential upside of 164.78%. Health In Tech has a consensus price target of $4.00, indicating a potential upside of 257.14%. Given Health In Tech's stronger consensus rating and higher probable upside, analysts clearly believe Health In Tech is more favorable than Octave Specialty Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Octave Specialty Group	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Health In Tech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50

Octave Specialty Group has a beta of 0.85, indicating that its share price is 15% less volatile than the broader market. Comparatively, Health In Tech has a beta of 2.82, indicating that its share price is 182% more volatile than the broader market.

Health In Tech has lower revenue, but higher earnings than Octave Specialty Group. Health In Tech is trading at a lower price-to-earnings ratio than Octave Specialty Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Octave Specialty Group	$251.22M	1.01	-$261.69M	-$4.86	N/A
Health In Tech	$34.08M	2.15	-$1.31M	-$0.02	N/A

80.9% of Octave Specialty Group shares are owned by institutional investors. 7.2% of Octave Specialty Group shares are owned by insiders. Comparatively, 77.7% of Health In Tech shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, Octave Specialty Group had 2 more articles in the media than Health In Tech. MarketBeat recorded 3 mentions for Octave Specialty Group and 1 mentions for Health In Tech. Octave Specialty Group's average media sentiment score of 0.30 beat Health In Tech's score of 0.00 indicating that Octave Specialty Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Octave Specialty Group	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Health In Tech	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Health In Tech has a net margin of 0.00% compared to Octave Specialty Group's net margin of -75.91%. Health In Tech's return on equity of 0.00% beat Octave Specialty Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Octave Specialty Group	-75.91%	-0.55%	-0.13%
Health In Tech	N/A	N/A	N/A

Summary

Health In Tech beats Octave Specialty Group on 11 of the 17 factors compared between the two stocks.

How does Health In Tech compare to James River Group?

James River Group (NASDAQ:JRVR) and Health In Tech (NASDAQ:HIT) are related small-cap companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, risk, valuation, media sentiment and analyst recommendations.

James River Group has a net margin of 4.34% compared to Health In Tech's net margin of 0.00%. James River Group's return on equity of 10.79% beat Health In Tech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
James River Group	4.34%	10.79%	1.13%
Health In Tech	N/A	N/A	N/A

James River Group has a beta of -0.2, suggesting that its stock price is 120% less volatile than the broader market. Comparatively, Health In Tech has a beta of 2.82, suggesting that its stock price is 182% more volatile than the broader market.

95.2% of James River Group shares are owned by institutional investors. 33.8% of James River Group shares are owned by company insiders. Comparatively, 77.7% of Health In Tech shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, James River Group had 3 more articles in the media than Health In Tech. MarketBeat recorded 4 mentions for James River Group and 1 mentions for Health In Tech. James River Group's average media sentiment score of 0.58 beat Health In Tech's score of 0.00 indicating that James River Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
James River Group	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Health In Tech	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

James River Group currently has a consensus target price of $6.44, indicating a potential upside of 34.39%. Health In Tech has a consensus target price of $4.00, indicating a potential upside of 257.14%. Given Health In Tech's stronger consensus rating and higher probable upside, analysts plainly believe Health In Tech is more favorable than James River Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
James River Group	1 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.86
Health In Tech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50

James River Group has higher revenue and earnings than Health In Tech. Health In Tech is trading at a lower price-to-earnings ratio than James River Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
James River Group	$687.61M	0.32	$47.43M	$0.34	14.09
Health In Tech	$34.08M	2.15	-$1.31M	-$0.02	N/A

Summary

James River Group beats Health In Tech on 10 of the 16 factors compared between the two stocks.

How does Health In Tech compare to AIFU?

AIFU (NASDAQ:AIFU) and Health In Tech (NASDAQ:HIT) are related small-cap companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, media sentiment, institutional ownership, risk, earnings, profitability, analyst recommendations and valuation.

Company	Net Margins	Return on Equity	Return on Assets
AIFU	N/A	N/A	N/A
Health In Tech	N/A	N/A	N/A

AIFU has a beta of 1.01, suggesting that its share price is 1% more volatile than the broader market. Comparatively, Health In Tech has a beta of 2.82, suggesting that its share price is 182% more volatile than the broader market.

Health In Tech has lower revenue, but higher earnings than AIFU. Health In Tech is trading at a lower price-to-earnings ratio than AIFU, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AIFU	$79.59M	2.81	-$325.38M	$228.00	0.16
Health In Tech	$34.08M	2.15	-$1.31M	-$0.02	N/A

Health In Tech has a consensus price target of $4.00, indicating a potential upside of 257.14%. Given Health In Tech's stronger consensus rating and higher possible upside, analysts plainly believe Health In Tech is more favorable than AIFU.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AIFU	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Health In Tech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50

26.7% of AIFU shares are owned by institutional investors. 25.6% of AIFU shares are owned by insiders. Comparatively, 77.7% of Health In Tech shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Health In Tech had 1 more articles in the media than AIFU. MarketBeat recorded 1 mentions for Health In Tech and 0 mentions for AIFU. AIFU's average media sentiment score of 0.00 equaled Health In Tech'saverage media sentiment score.

Company	Overall Sentiment
AIFU	Neutral
Health In Tech	Neutral

Summary

Health In Tech beats AIFU on 7 of the 12 factors compared between the two stocks.

How does Health In Tech compare to SelectQuote?

Health In Tech (NASDAQ:HIT) and SelectQuote (NYSE:SLQT) are related small-cap companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, earnings, institutional ownership, dividends, valuation, risk and media sentiment.

SelectQuote has a net margin of 5.60% compared to Health In Tech's net margin of 0.00%. SelectQuote's return on equity of 20.49% beat Health In Tech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Health In Tech	N/A	N/A	N/A
SelectQuote	5.60%	20.49%	5.58%

Health In Tech presently has a consensus target price of $4.00, suggesting a potential upside of 257.14%. SelectQuote has a consensus target price of $3.00, suggesting a potential upside of 336.68%. Given SelectQuote's higher possible upside, analysts plainly believe SelectQuote is more favorable than Health In Tech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Health In Tech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50
SelectQuote	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.25

34.6% of SelectQuote shares are held by institutional investors. 77.7% of Health In Tech shares are held by company insiders. Comparatively, 13.1% of SelectQuote shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

SelectQuote has higher revenue and earnings than Health In Tech. Health In Tech is trading at a lower price-to-earnings ratio than SelectQuote, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Health In Tech	$34.08M	2.15	-$1.31M	-$0.02	N/A
SelectQuote	$1.53B	0.08	$47.58M	$0.09	7.63

In the previous week, Health In Tech and Health In Tech both had 1 articles in the media. Health In Tech's average media sentiment score of 0.00 equaled SelectQuote'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Health In Tech	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
SelectQuote	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Health In Tech has a beta of 2.82, meaning that its stock price is 182% more volatile than the broader market. Comparatively, SelectQuote has a beta of 1.66, meaning that its stock price is 66% more volatile than the broader market.

Summary

SelectQuote beats Health In Tech on 9 of the 13 factors compared between the two stocks.

Get Health In Tech News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HIT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HIT vs. The Competition

Export

Metric	Health In Tech	Healthcare Technology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$73.39M	$1.45B	$6.95B	$12.87B
Dividend Yield	N/A	4.74%	2.59%	9.95%
P/E Ratio	-56.00	22.02	270.82	25.32
Price / Sales	2.15	67.42	599.74	83.09
Price / Cash	N/A	30.92	71.89	50.37
Price / Book	N/A	5.82	13.00	6.13
Net Income	-$1.31M	-$25.90M	$3.46B	$342.95M
7 Day Performance	7.69%	4.97%	2.64%	3.03%
1 Month Performance	14.86%	-0.93%	-2.64%	-3.04%
1 Year Performance	-48.62%	-18.42%	76.00%	20.65%

Health In Tech Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HIT Health In Tech	1.323 of 5 stars	$1.12 -3.4%	$4.00 +257.1%	-47.0%	$73.39M	$34.08M	N/A	79
KWY Kingsway Financial Services	0.4669 of 5 stars	$8.68 +0.8%	N/A	-34.9%	$251.84M	$134.97M	N/A	280	News Coverage Earnings Report
OSG Octave Specialty Group	3.9391 of 5 stars	$5.59 +0.8%	$15.00 +168.6%	N/A	$251.63M	$251.22M	N/A	130	News Coverage Earnings Report
JRVR James River Group	4.0501 of 5 stars	$4.71 +4.2%	$6.44 +36.7%	-15.9%	$217.78M	$687.61M	13.85	640	Positive News
AIFU AIFU	1.4175 of 5 stars	$34.00 -0.1%	N/A	-73.4%	$209.91M	$79.59M	0.15	4,707	Analyst Forecast Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:HIT) was last updated on 8/6/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Health In Tech (HIT) Competitors

HIT vs. KWY, OSG, JRVR, AIFU, and SLQT

How does Health In Tech compare to Kingsway Financial Services?

Summary

How does Health In Tech compare to Octave Specialty Group?

Summary

How does Health In Tech compare to James River Group?

Summary

How does Health In Tech compare to AIFU?

Summary

How does Health In Tech compare to SelectQuote?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HIT vs. The Competition

Health In Tech Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Health In Tech (HIT) Competitors

HIT vs. KWY, OSG, JRVR, AIFU, and SLQT

How does Health In Tech compare to Kingsway Financial Services?

Which has higher earnings and valuation, HIT or KWY?

Which has more volatility and risk, HIT or KWY?

Does the media favor HIT or KWY?

Do analysts prefer HIT or KWY?

Is HIT or KWY more profitable?

Do institutionals & insiders have more ownership in HIT or KWY?

Summary

How does Health In Tech compare to Octave Specialty Group?

Do analysts prefer OSG or HIT?

Which has more risk and volatility, OSG or HIT?

Which has higher valuation and earnings, OSG or HIT?

Do insiders and institutionals believe in OSG or HIT?

Does the media prefer OSG or HIT?

Is OSG or HIT more profitable?

Summary

How does Health In Tech compare to James River Group?

Is JRVR or HIT more profitable?

Which has more risk and volatility, JRVR or HIT?

Do insiders & institutionals believe in JRVR or HIT?

Does the media prefer JRVR or HIT?

Do analysts recommend JRVR or HIT?

Which has higher earnings and valuation, JRVR or HIT?

Summary

How does Health In Tech compare to AIFU?

Is AIFU or HIT more profitable?

Which has more volatility and risk, AIFU or HIT?

Which has preferable valuation and earnings, AIFU or HIT?

Do analysts recommend AIFU or HIT?

Do institutionals and insiders believe in AIFU or HIT?

Does the media prefer AIFU or HIT?

Summary

How does Health In Tech compare to SelectQuote?

Is HIT or SLQT more profitable?

Do analysts recommend HIT or SLQT?

Do institutionals & insiders hold more shares of HIT or SLQT?

Which has preferable earnings & valuation, HIT or SLQT?

Does the media refer more to HIT or SLQT?

Which has more volatility & risk, HIT or SLQT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HIT vs. The Competition

Health In Tech Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools